KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Cash (2016 - 2025)

Historic Change in Cash for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Eli Lilly's Change in Cash rose 431265.47% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 54995.95%. This contributed to the annual value of $449.8 million for FY2024, which is 4015.43% down from last year.
  • Latest data reveals that Eli Lilly reported Change in Cash of $6.4 billion as of Q3 2025, which was up 431265.47% from $282.6 million recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Change in Cash ranged from a high of $6.4 billion in Q3 2025 and a low of -$1.4 billion during Q1 2022
  • Moreover, its 5-year median value for Change in Cash was $30.3 million (2021), whereas its average is $322.9 million.
  • Per our database at Business Quant, Eli Lilly's Change in Cash plummeted by 560363.64% in 2023 and then soared by 431265.47% in 2025.
  • Eli Lilly's Change in Cash (Quarter) stood at $30.3 million in 2021, then tumbled by 1916.5% to -$550.4 million in 2022, then skyrocketed by 179.54% to $437.8 million in 2023, then plummeted by 122.98% to -$100.6 million in 2024, then surged by 6477.73% to $6.4 billion in 2025.
  • Its last three reported values are $6.4 billion in Q3 2025, $282.6 million for Q2 2025, and -$175.1 million during Q1 2025.